Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.34 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.34 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8440385 | 0.88 | DPP8 (0.37) | DPP8DPP9KCNJ1KCNH2MGLL | |
| SCHEMBL8435665 | 0.85 | KCNJ1 (0.38) | RECQLKCNJ1KCNH2 | |
| SCHEMBL9207326 | 0.81 | TDP1 (0.42) | RECQL | |
| SCHEMBL9126331 | 0.75 | KCNJ1 (0.39) | KCNJ1KCNH2NPBWR1MCHR1 | |
| SCHEMBL8438315 | 0.75 | KCNJ1 (0.39) | KCNJ1KCNH2NPBWR1MCHR1 | |
| SCHEMBL9728630 | 0.75 | GAA (0.44) | KCNJ1KCNH2 | |
| SCHEMBL9728638 | 0.75 | GAA (0.44) | KCNJ1KCNH2 | |
| SCHEMBL8543784 | 0.75 | KCNJ1 (0.39) | OPRK1KCNJ1KCNH2 | |
| SCHEMBL8438015 | 0.75 | KCNJ1 (0.39) | OPRK1KCNJ1KCNH2 | |
| SCHEMBL8438589 | 0.74 | KCNJ1 (0.42) | KCNJ1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5712267-A | Carbapenem derivatives, their preparation and their use as antibiotics | SANKYO COMPANY,. LIMITED (JP) | 1998-01-27 | — | — | US | disclosed |